Tranexamic acid increases early perioperative functional outcomes after total knee arthroplasty

Background: The purpose of this study was to investigate the influence of tranexamic acid (TXA) on functional outcomes in the immediate postoperative period after total knee arthroplasty (TKA). We hypothesized that the known benefits of TXA would confer measurable clinical improvements in physical t...

Full description

Bibliographic Details
Main Authors: Matthew J. Grosso, MD, David P. Trofa, MD, Jonathan R. Danoff, MD, Thomas R. Hickernell, MD, Taylor Murtaugh, BS, Akshay Lakra, MD, Jeffrey A. Geller, MD
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:Arthroplasty Today
Online Access:http://www.sciencedirect.com/science/article/pii/S2352344117300481
id doaj-5dadabb9f40842e488221a21b101f127
record_format Article
spelling doaj-5dadabb9f40842e488221a21b101f1272020-11-25T01:39:13ZengElsevierArthroplasty Today2352-34412018-03-01417477Tranexamic acid increases early perioperative functional outcomes after total knee arthroplastyMatthew J. Grosso, MD0David P. Trofa, MD1Jonathan R. Danoff, MD2Thomas R. Hickernell, MD3Taylor Murtaugh, BS4Akshay Lakra, MD5Jeffrey A. Geller, MD6New York Orthopaedic Hospital, Columbia University Medical Center, New York, NY, USANew York Orthopaedic Hospital, Columbia University Medical Center, New York, NY, USANew York Orthopaedic Hospital, Columbia University Medical Center, New York, NY, USANew York Orthopaedic Hospital, Columbia University Medical Center, New York, NY, USANew York Orthopaedic Hospital, Columbia University Medical Center, New York, NY, USANew York Orthopaedic Hospital, Columbia University Medical Center, New York, NY, USACorresponding author. Chief Division of Hip & Knee Reconstruction, New York-Presbyterian at Columbia University, 622 West 168th Street, PH 1147, New York, NY 10032, USA. Tel.: +1 212 305 1120.; New York Orthopaedic Hospital, Columbia University Medical Center, New York, NY, USABackground: The purpose of this study was to investigate the influence of tranexamic acid (TXA) on functional outcomes in the immediate postoperative period after total knee arthroplasty (TKA). We hypothesized that the known benefits of TXA would confer measurable clinical improvements in physical therapy (PT) performance, decrease pain, and decrease hospital length of stay (LOS). Methods: We retrospectively analyzed 560 TKA patients, including 280 consecutive patients whose surgery was performed before the initiation of a standardized TXA protocol and the first 280 patients who received TXA after protocol initiation. Outcome measurements included postoperative changes in hemoglobin and hematocrit, LOS, pain scores, destination of discharge, and steps ambulated with PT over 5 sessions. Results: TXA administration resulted in less overall drops in hemoglobin (P < .001) and hematocrit levels (P < .001). Moreover, patients administered TXA ambulated more than their counterparts during every PT session, which was statistically significant during the second (P = .010), third (P = .011), and fourth (P = .024) sessions. On average, the TXA cohort ambulated 20% more per PT session than patients who did not receive TXA (P < .001). TXA administration did not influence pain levels during PT, hospital LOS, or discharge destination in this investigation. Conclusions: It is well known that TXA reduces postoperative anemia, but this study also demonstrates that it confers early perioperative functional benefits for TKA patients. Potential mechanisms for this benefit include reduced rates of postoperative anemia and reduced rates of hemarthroses. Keywords: Tranexamic acid, Total knee arthroplasty, Blood loss, Physical therapyhttp://www.sciencedirect.com/science/article/pii/S2352344117300481
collection DOAJ
language English
format Article
sources DOAJ
author Matthew J. Grosso, MD
David P. Trofa, MD
Jonathan R. Danoff, MD
Thomas R. Hickernell, MD
Taylor Murtaugh, BS
Akshay Lakra, MD
Jeffrey A. Geller, MD
spellingShingle Matthew J. Grosso, MD
David P. Trofa, MD
Jonathan R. Danoff, MD
Thomas R. Hickernell, MD
Taylor Murtaugh, BS
Akshay Lakra, MD
Jeffrey A. Geller, MD
Tranexamic acid increases early perioperative functional outcomes after total knee arthroplasty
Arthroplasty Today
author_facet Matthew J. Grosso, MD
David P. Trofa, MD
Jonathan R. Danoff, MD
Thomas R. Hickernell, MD
Taylor Murtaugh, BS
Akshay Lakra, MD
Jeffrey A. Geller, MD
author_sort Matthew J. Grosso, MD
title Tranexamic acid increases early perioperative functional outcomes after total knee arthroplasty
title_short Tranexamic acid increases early perioperative functional outcomes after total knee arthroplasty
title_full Tranexamic acid increases early perioperative functional outcomes after total knee arthroplasty
title_fullStr Tranexamic acid increases early perioperative functional outcomes after total knee arthroplasty
title_full_unstemmed Tranexamic acid increases early perioperative functional outcomes after total knee arthroplasty
title_sort tranexamic acid increases early perioperative functional outcomes after total knee arthroplasty
publisher Elsevier
series Arthroplasty Today
issn 2352-3441
publishDate 2018-03-01
description Background: The purpose of this study was to investigate the influence of tranexamic acid (TXA) on functional outcomes in the immediate postoperative period after total knee arthroplasty (TKA). We hypothesized that the known benefits of TXA would confer measurable clinical improvements in physical therapy (PT) performance, decrease pain, and decrease hospital length of stay (LOS). Methods: We retrospectively analyzed 560 TKA patients, including 280 consecutive patients whose surgery was performed before the initiation of a standardized TXA protocol and the first 280 patients who received TXA after protocol initiation. Outcome measurements included postoperative changes in hemoglobin and hematocrit, LOS, pain scores, destination of discharge, and steps ambulated with PT over 5 sessions. Results: TXA administration resulted in less overall drops in hemoglobin (P < .001) and hematocrit levels (P < .001). Moreover, patients administered TXA ambulated more than their counterparts during every PT session, which was statistically significant during the second (P = .010), third (P = .011), and fourth (P = .024) sessions. On average, the TXA cohort ambulated 20% more per PT session than patients who did not receive TXA (P < .001). TXA administration did not influence pain levels during PT, hospital LOS, or discharge destination in this investigation. Conclusions: It is well known that TXA reduces postoperative anemia, but this study also demonstrates that it confers early perioperative functional benefits for TKA patients. Potential mechanisms for this benefit include reduced rates of postoperative anemia and reduced rates of hemarthroses. Keywords: Tranexamic acid, Total knee arthroplasty, Blood loss, Physical therapy
url http://www.sciencedirect.com/science/article/pii/S2352344117300481
work_keys_str_mv AT matthewjgrossomd tranexamicacidincreasesearlyperioperativefunctionaloutcomesaftertotalkneearthroplasty
AT davidptrofamd tranexamicacidincreasesearlyperioperativefunctionaloutcomesaftertotalkneearthroplasty
AT jonathanrdanoffmd tranexamicacidincreasesearlyperioperativefunctionaloutcomesaftertotalkneearthroplasty
AT thomasrhickernellmd tranexamicacidincreasesearlyperioperativefunctionaloutcomesaftertotalkneearthroplasty
AT taylormurtaughbs tranexamicacidincreasesearlyperioperativefunctionaloutcomesaftertotalkneearthroplasty
AT akshaylakramd tranexamicacidincreasesearlyperioperativefunctionaloutcomesaftertotalkneearthroplasty
AT jeffreyagellermd tranexamicacidincreasesearlyperioperativefunctionaloutcomesaftertotalkneearthroplasty
_version_ 1725049787800092672